Dr. Charles W. Flexner, M.D.
Internal Medicine (Internal Medicine Physician)
600 N Wolfe St
Baltimore, MD 21287
Who else practices at this address →
Baltimore city includes primary care (36% of residents) shortage areas. About shortage areas
At a glance
- In the NPI registry since
- 2006
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Internal Medicine Physician primary
MD license D32845 -
Infectious Disease Physician
MD license D32845
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Payments from drug and device companies
In 2025, 3 companies reported 29 payments worth $21,624 in total to this clinician.
| Merck Sharp & Dohme LLC | $11,001 |
|---|---|
| Gilead Sciences, Inc. | $7,622 |
| Theratechnologies Inc. | $3,000 |
| Consulting Fee | $15,230 |
|---|---|
| Honoraria | $3,000 |
| Travel and Lodging | $2,254 |
| Food and Beverage | $1,139 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC Oct 15, 2025 | Consulting Fee | $9,280 |
| Gilead Sciences, Inc. Dec 8, 2025 | Consulting Fee Sunlenca · HIV Company’s description;4288167;GTF;10161586 | $5,950 |
| Theratechnologies Inc. Jun 1, 2025 | Honoraria | $3,000 |
| Gilead Sciences, Inc. Nov 13, 2025 | Travel and Lodging Sunlenca · HIV · travel to Boston, MA · in-kind Company’s description;4288231;GTF;10161586 | $406 |
| Gilead Sciences, Inc. Nov 14, 2025 | Travel and Lodging Sunlenca · HIV · travel to Boston, MA · in-kind Company’s description;4288207;GTF;10161586 | $313 |
| Merck Sharp & Dohme LLC Sep 28, 2025 | Travel and Lodging INFECTIOUS DISEASE · travel to Philadelphia, PA · in-kind | $275 |
| Merck Sharp & Dohme LLC Sep 29, 2025 | Travel and Lodging INFECTIOUS DISEASE · travel to Philadelphia, PA · in-kind | $260 |
| Merck Sharp & Dohme LLC Sep 28, 2025 | Travel and Lodging INFECTIOUS DISEASE · travel to Philadelphia, PA · in-kind | $260 |
| Merck Sharp & Dohme LLC Sep 28, 2025 | Travel and Lodging INFECTIOUS DISEASE · travel to Philadelphia, PA · in-kind | $171 |
| Gilead Sciences, Inc. Nov 13, 2025 | Travel and Lodging Sunlenca · HIV · travel to Boston, MA · in-kind Company’s description;4288253;GTF;10161586 | $160 |
All 14 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Gilead Sciences, Inc. Dec 8, 2025 | Consulting Fee Sunlenca · HIV Company’s description;4288167;GTF;10161586 | $5,950 |
| Gilead Sciences, Inc. Nov 14, 2025 | Travel and Lodging Sunlenca · HIV · travel to Boston, MA · in-kind Company’s description;4288207;GTF;10161586 | $313 |
| Gilead Sciences, Inc. Nov 14, 2025 | Travel and Lodging Sunlenca · HIV · travel to Boston, MA Company’s description;4288180;GTF;10161586 | $60.00 |
| Gilead Sciences, Inc. Nov 14, 2025 | Travel and Lodging Sunlenca · HIV · travel to Boston, MA · in-kind Company’s description;4288190;GTF;10161586 | $58.30 |
| Gilead Sciences, Inc. Nov 13, 2025 | Travel and Lodging Sunlenca · HIV · travel to Boston, MA · in-kind Company’s description;4288231;GTF;10161586 | $406 |
| Gilead Sciences, Inc. Nov 13, 2025 | Travel and Lodging Sunlenca · HIV · travel to Boston, MA · in-kind Company’s description;4288253;GTF;10161586 | $160 |
| Merck Sharp & Dohme LLC Oct 15, 2025 | Consulting Fee | $9,280 |
| Merck Sharp & Dohme LLC Oct 15, 2025 | Travel and Lodging travel to Philadelphia, PA | $150 |
| Merck Sharp & Dohme LLC Sep 29, 2025 | Travel and Lodging INFECTIOUS DISEASE · travel to Philadelphia, PA · in-kind | $260 |
| Merck Sharp & Dohme LLC Sep 28, 2025 | Travel and Lodging INFECTIOUS DISEASE · travel to Philadelphia, PA · in-kind | $275 |
| Merck Sharp & Dohme LLC Sep 28, 2025 | Travel and Lodging INFECTIOUS DISEASE · travel to Philadelphia, PA · in-kind | $260 |
| Merck Sharp & Dohme LLC Sep 28, 2025 | Travel and Lodging INFECTIOUS DISEASE · travel to Philadelphia, PA · in-kind | $171 |
| Merck Sharp & Dohme LLC Sep 28, 2025 | Travel and Lodging INFECTIOUS DISEASE · travel to Philadelphia, PA · in-kind | $140 |
| Theratechnologies Inc. Jun 1, 2025 | Honoraria | $3,000 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.